Combination of approved drugs offers new strategies for acute myeloid leukemia

The combined use of two well-known active substances can fight leukemic cells and limit their spread. This is the result of a study conducted by the Karl Landsteiner University of Health Sciences (KL Krems) and published in the journal Cancer Letters.

Leave A Comment

Your email address will not be published. Required fields are marked *